Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

IDDO and MORU released its Medicine Quality Scientific Literature Surveyor. The surveyor delivers summaries of published scientific reports on the quality of the classes of essential medicines listed below, across regions and over time. We hope it will help medicine regulators, scientists, health professionals, purchasers and officials fill critical information gaps.

Africa and Asia map showing locations of Medicine Quality Scientific Literature Surveyor

Substandard and falsified (SF) medical products (medicines, vaccines, diagnostic tests and devices) pose an immediate danger to many people worldwide, and in the case of anti-infectives, they could also increase the threat of drug resistance emerging and spreading. A major challenge in preventing this is a lack of accessible and reliable information on how widespread they really are. This new mapping tool visualises these data and it will help scientists, health professionals and officials fill critical information gaps. 

Funded by Wellcome, the tool delivers summaries of published scientific reports on the quality of communicable diseases (antimalarials, antiretrovirals, antibiotics, anti-tuberculosis) non-communicable diseases (antidiabetics and medical devices for diabetes management, cardiovascular medicines and medical devices), veterinary medicines, and vaccines across regions and over time, both in English and French.

It builds on the success of the Medicine Quality team’s work on WWARN’s existing Antimalarial Surveyor and future phased releases are planned that will expand its reach to other medical products.  

With increasing number of reports in the scientific literature of substandard and falsified medical products for diagnosis, treatment and prevention of COVID-19 we are developing a Surveyor database and map for these, including past reports of SF medicines being repurposed for COVID-19.

Read more on the IDDO website

Similar stories

Pilot study detects diverse DNA in ingredients of falsified tablets

A recent multidisciplinary pilot study, originating from LOMWRU and the Medicine Quality Research Group of IDDO and MORU, investigated whether bacterial, plant, fungal and animal DNA in the ingredients and from the environment (eDNA) could be detected from falsified (aka counterfeit) tablets.

Expert Comment: Biotechnology allows us to make unprecedented interventions for conservation

In the wake of high-profile reports on the devastating toll human activity has had on global biodiversity, nations are expected to adopt the Convention on Biodiversity post-2020 framework that outlines measures to ensure humans live in harmony with nature.

Researchers call for antimicrobial resistance surveillance to be improved

The number of studies reporting antimicrobial resistance (AMR) data has increased in Africa, South and South East Asia according to new research in the International Journal of Infectious Diseases.

Meta-analysis informed the updated WHO guidelines for treatment of uncomplicated malaria in the first trimester of pregnancy

A new WWARN meta-analysis, commissioned by the World Health Organization and which informed a change to its treatment guidelines, has been published in The Lancet. The study provides compelling evidence that artemether-lumefantrine should now replace quinine as the treatment of choice in the first trimester.

Bacterial infections linked to one in eight global deaths, according to GRAM study

Data showing 7.7 million deaths from 33 bacterial infections can guide measures to strengthen health systems, particularly in low-income settings

GRAM visualization tool tracks country-level AMR and related metrics

Interactive app allows users to explore data underlying estimates of global AMR burden